In addition to anti IL-6 mABs, high IL-6 asthma with concomitant obesity and metabolic dysfunction may see further benefits with weight loss and management of metabolic diseases. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.